Bioclinica acquisition

Date

October 24, 2024

Author
Reading time

5 min

We are pleased to announce the acquisition of Casa Spadijer Bioclinica d.o.o, a well-known dietary supplements company, with over 20 years of successful business in the territory of the Republic of Serbia. This acquisition marks an important step in the expansion of INPHARM CO’s business activities in the field of dietary supplements. Casa Spadijer Bioclinica d.o.o.

Thanks to the quality of its products and commitment to innovation and expertise, it has become a recognizable brand not only in Serbia, but also in Montenegro and Bosnia and Herzegovina. The product range includes dietary supplements based on natural ingredients, with consistent adherence to high quality standards, thanks to which it has gained recognition and trust among its users.

This strategic decision is part of INPHARM CO’s long-term vision of growth and development, which will enable this acquisition to expand its product range, expand into new markets, as well as further improve production and service standards in accordance with the highest international regulations.

View our other articles

Explore the latest advancements, tips for maintaining wellness, and insights into natural medicine. Make informed decisions about your health journey!

Montenegro distribution

InPharm Serbia established its daughter company in Montenegro in 2010. Our company has become the marketing authorization holder of the permit for the placing the drug on the market, for the company Johnson & Johnson in Montenegro. The company is

Bosnia & Herzegovina and Albania distribution

Sun Wave Group entered the Albanian market in 2023 through cooperation with a partner. In 2023 we launched Sun Wave and Inpharm portfolio. We have great plans in Albania in 2024 and years to come. For 2024 we have further